ERC Pharma
The computed 12-month bankruptcy probability of ERC Pharma is 2.0% (moderate). The 2024 annual accounts show negative equity (€-52k) and a net result of €-152k. Its solvency ranks better than 25% of 3351 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-52k |
| Net result | €-152k |
| Better than sector | 25% |
| Active | 2 yrs |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -1.4% | 25.2% | |
| Net result | €-152k | €4k | |
| Equity | €-52k | €23k | |
| Gross operating margin | €-49k | €19k | |
| Total assets | €3.70M | €105k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-49k |
| Net profit | €-152k |
| Cash flow | €-130k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €3.70M |
| Equity | €-52k |
| Debt | €3.75M |
| of which ≤ 1y | €1.74M |
| of which > 1y | €2.01M |
| Working capital | €-1.28M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.26 |
| Quick ratio | 0.26 |
| Working capital ratio | -34.6% |
| Solvency | -1.4% |
| Debt / equity | -72.19 |
| Long-term debt ratio | -38.73 |
| Interest coverage | -0.59 |
| Gross margin | - |
| Net margin | - |
| ROA | -4.1% |
| ROE | 292.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.70M |
| Fixed assets | 21/28 | €3.24M |
| Formation expenses | 20 | €2k |
| Tangible fixed assets | 22/27 | €590k |
| Financial fixed assets | 28 | €2.65M |
| Current assets | 29/58 | €459k |
| Amounts receivable within one year | 40/41 | €459k |
| Cash & bank | 54/58 | €36 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.70M |
| Equity | 10/15 | €-52k |
| Contributions / capital | 10/11 | €100k |
| Accumulated profits (losses) | 14 | €-152k |
| Amounts payable | 17/49 | €3.75M |
| Amounts payable after one year | 17 | €2.01M |
| Amounts payable within one year | 42/48 | €1.74M |
| Trade debts payable within one year | 44 | €1k |
| Income statement | ||
| Gross operating margin | 9900 | €-49k |
| Operating result | 9901 | €-71k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €83k |
| Result before taxes | 9903 | €-152k |
| Net result for the period | 9904 | €-152k |
| Result to be appropriated | 9905 | €-152k |
| NACE primary | Wholesale trade(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 09-11-2023 |
| Status | Active |
| Postal code | 5032 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92065B0056/00V002 | Wallonia | 794 m² | 1 · 721 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
31-03-2025 2 directors appointed, 2 resigning
- Apostolos STATHOPOULOS, Gedelegeerd bestuurder
- Agamemnon VARONOS, Bestuurder
- Mohamad KASSAS, Bestuurder
- Bernard QUESTIER, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Mohamad KASSAS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-01-16",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a valid\u00E9 qu\u0027\u00E0 compter du 16 janvier 2025, Monsieur Mohamad KASSAS cesse ses mandats d\u0027administrateur et d\u0027administrateur-d\u00E9l\u00E9gu\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bernard QUESTIER",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-01-16",
"evidence_quote": "Monsieur Bernard QUESTIER cesse son mandat d\u0027administrateur qu\u0027ils exer\u00E7aient \u00E0 titre gratuit.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Apostolos STATHOPOULOS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-01-16",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a valid\u00E9 qu\u0027\u00E0 compter du 16 janvier 2025, Monsieur Apostolos STATHOPOULOS sera nomm\u00E9 administrateur-d\u00E9l\u00E9gu\u00E9 de la soci\u00E9t\u00E9 \u00E0 titre gratuit.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2029"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Agamemnon VARONOS",
"address": "Op der Tonn 75, L-6188 GONDERANGE",
"birth_date": "1972-03-19",
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-01-16",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale approuve la nomination de Monsieur Agamemnon VARONOS, n\u00E9 le 19 mars 1972 et demeurant Op der Tonn 75, L-6188 GONDERANGE, comme administrateur.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2029"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-03-31",
"filing_date": "2025-03-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-01-16",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "1002.131.150",
"name_full": "ERC PHARMA",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | ERC Pharma |